Short answer
Azenta, Inc. (AZTA) filed its Q2 2026 10-Q quarterly report on Aug 6, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $161M (up 12.0% year over year) with net income of $2M.
Q2 2026 key financials · XBRL
- Revenue
- $161M
- +12.0% YoY · +11.3% QoQ
- Net income
- $2M
- +104.7% YoY · +101.5% QoQ
- Operating margin
- -2.6%
- Gross margin
- 44.9%
- EPS (diluted)
- $0.03
- +102.6% YoY · +100.9% QoQ
Source: XBRL data from the Azenta, Inc. (AZTA) Q2 2026 10-Q on SEC EDGAR. USD.
Azenta, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- B Medical Systems sold July 1, 2026 for $63.0 million, including $28.0 million cash and $35.0 million vendor financing
- MD&A notes revised June 30, 2025 figures for previously identified financial-statement errors
Risk Factors
- New credit risk triggered by July 1, 2026 B Medical Systems divestiture and $35.0 million secured buyer loan
- Buyer repayment risk: $35.0 million principal plus 6.0% interest due three months after funding
- Related-party enforcement risk from buyer majority ownership by an Azenta officer
- Collateral recovery risk limited to pledged B Medical Systems equity
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Azenta, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.